Clinical tolerance of cutaneous antiseptics in 3403 patients in France;Tolérance clinique des antiseptiques cutanés chez 3 403 malades en pratique de ville

Annales de Dermatologie et de Venereologie

Volumn 133, Issue 10, 2006, Pages 755-760

  Caumes, E ^a   Le Maitre, M ^b   Garnier, J M ^c   Bricaire, F ^a   Crickx, B ^d  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Hôpital Nord ^*  (France)

^c HÔPITAL NORD   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIINFECTIVE AGENT; BENZALKONIUM; CHLORHEXIDINE; CORTICOSTEROID; HEXAMIDINE; POVIDONE IODINE;

ADULT; AGED; AMBULATORY SURGERY; ANAMNESIS; ANTISEPSIS; APPLICATION SITE BURNING; AQUEOUS SOLUTION; ARTICLE; BURN; CONFIDENCE INTERVAL; CONTACT DERMATITIS; CORTICOSTEROID THERAPY; DERMATOLOGY; EVALUATION; FEMALE; FRANCE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT CARE; PHYSICIAN; PRESCRIPTION; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SKIN ALLERGY; SKIN BURNING SENSATION; SKIN DISCOLORATION; SKIN DISEASE; SKIN MANIFESTATION; TELEPHONE; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT WITHDRAWAL; WOUND;

EID: 33750046292     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(06)71038-9     Document Type: Article

References (19)

1. Fleurette J, Freney J, Reverdy ME. Antisepsie et désinfection. Éditions Alaska, Paris, 1995: 639 pages.
2. AFSSAPS. Prescription des antibiotiques par voie locale dans les infections cutanées primitives et secondaires - juillet 2004. http://agmed.sante.gouv.fr/pdf/5/rbp/dermagu.pdf
3. Wolkenstein P, Vaillant L. Les antiseptiques en peau lésée. Ann Dermatol Venereol 1996;123:343-8.
4. Begaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode utilisée en France. Thérapie 1985;40:111-8.
5. Prescription des antiseptiques en France (Doréma, cumul mobile 02/ 2003).
6. Le Coz CJ, Scrivener Y, Santinelli F, Heid E. Sensibilisation de contact au cours des ulcères de jambe. Ann Dermatol Venereol 1998;125:694-9.
7. Gonzalo MA, Revenga F, Caravaca F, Pizarro JL. Epidemiologic study of contact dermatitis in hemodialysis patients. Invest Allergol Clin Immunol 1997;7:20-3.
8. Goossens A, Claes L, Drieghe J, Put E. Antimicrobials: preservatives, antiseptics and disinfectants. Contact Dermatitis 1997;39:133-4.
9. Tupker RA, Schuur J, Coenraads PJ. Irritancy of antiseptics tested by repeated open exposures on the human skin, evaluated by non-invasive methods. Contact Dermatitis 1997;37:213-7.
10. Revuz J, Poli F, Wechsler J, Dubertret L Dermite de contact à l'hexamidine. Ann Dermatol Venereol 1984;111:805-10.
11. Wong DA, Watson AB. Allergic contact dermatitis due to benzalkonium chloride in plaster of Paris. Austr J Dermatol 2001;42:33-5.
12. Bergqvist-Karlsson A. Delayed and immediate-type hypersensitivity to chlorhexidine. Contact Dermatitis 1988;18:84-8.
13. Lauerma AI. Simultaneous immediate and delayed hypersensitivity to chlorhexidine digluconate. Contact Dermatitis 2001;44:59.
14. Nishioka K, Seguchi T, Yasuno H, Yamamoto T, Tominaga K. The results of ingredient patch testing in contact dermatitis elicited by povidone-iodine preparations. Contact Dermatitis 2000;42:90-4.
15. Lijima S, Kuramochi M. Investigation of irritant skin reaction by 10% povidone-iodine solution after surgery. Dermatology 2002;204(suppl. 1):103-8.
16. Niedner R. Cytotoxicity and sensitization of povidone-iodine and other frequently used anti-infective agents. Dermatology 1997;195(suppl. 2):89-92.
17. Ebo DG, Stevens WJ, Bridts CH, Matthieu L. Contact allergic dermatitis and life-threatening anaphylaxis to chlorhexidine. J Allergy Clin Immunol 1998;101:128-9.
18. Autegarden JE, Pecquet C, Huet S, Bayrou O, Leynadier F. Anaphylactic shock after application of chlorhexidine to unbroken skin. Contact Dermatitis 1999;40:215.
19. Paramsothy Y, Collins M, Smith G. Contact dermatitis in patients with leg ulcers. The prevalence of late positive reactions and evidence against systemic ampliative allergy. Contact Dermatitis 1988;18:30-6.